Assessment of the health system and policy environment as a critical complement to tracking intervention coverage for maternal, newborn, and child health

Lancet
Countdown Working Group on Health Policy and Health SystemsAnuraj Shankar

Abstract

In 2008, the Countdown to 2015 initiative identified 68 priority countries for action on maternal, newborn, and child health. Much attention was paid to monitoring country-level progress in achieving high and equitable coverage with interventions effective in reducing mortality of mothers, newborn infants, and children up to 5 years of age. To have a broader understanding of the environment in which health services are delivered and health outcomes are produced is essential to increase intervention coverage. Programmes to address MNCH rely on health systems to generate information needed for effective decisions and to achieve the expected outcomes. Governance and leadership are needed throughout the process not only to create policies and implement them but also to assure quality and efficiency of care, to finance health services sufficiently and in an equitable way, and to manage the health workforce. We present a systematic approach to assess the wider health system and policy environment needed to achieve positive outcomes for maternal, newborn, and child health. We report on results from 13 indicators and show gaps in policy adoption as well as weaknesses in other health system building blocks. We identify areas for future ...Continue Reading

References

May 27, 1999·Health Policy and Planning·S Nahar, A Costello
Dec 13, 2002·Health Policy and Planning·Zhan ShaokangErik Blas
Feb 1, 2003·Reproductive Health Matters·Joan Kaufman, Fang Jing
Sep 26, 2006·Lancet·Jennifer BryceTessa Wardlaw
Oct 3, 2006·Lancet·Carine RonsmansUNKNOWN Lancet Maternal Survival Series steering group
Oct 24, 2006·Lancet·Jo BorghiUNKNOWN Lancet Maternal Survival Series steering group
Feb 8, 2007·Statistics in Medicine·Joe MurphyDeborah J Walker
Mar 6, 2007·Lancet·J Ties Boerma, Sally K Stansfield
Jun 19, 2007·Lancet·Fitzhugh Mullan, Seble Frehywot
Mar 11, 2008·Lancet·Michael R ReichWilliam C Hsiao

❮ Previous
Next ❯

Citations

Jun 22, 2012·Health Policy and Planning·Allisyn C MoranJeremy Shiffman
Mar 24, 2012·BMC Pregnancy and Childbirth·Rose Nathan, Mathew Alexander Mwanyangala
Oct 12, 2013·Human Resources for Health·Jesse A GreenspanPeter J Winch
Mar 30, 2011·International Archives of Medicine·Joses Muthuri Kirigia, Doris Gatwiri Kirigia
Feb 2, 2013·PloS One·Thomas van den AkkerJos van Roosmalen
Sep 21, 2013·Bulletin of the World Health Organization·Hapsatou TouréUNKNOWN PMTCT Costing Multi-country Team
Jun 30, 2009·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Per Ole Iversen
Mar 10, 2009·Lancet·Hanan F Abdul RahimMarwan Khawaja
Apr 15, 2008·Lancet·Peter SalamaElizabeth Mason
Apr 18, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·Paul McNameeJulia Hussein
Jun 9, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·C Wendy Spearman, Mark W Sonderup
Sep 17, 2016·BMC Public Health·Neha S SinghUNKNOWN Countdown to 2015 Health Systems and Policies Technical Working Group
Nov 26, 2009·International nursing review·I A KhalafA F Zomot
Mar 25, 2009·Immunology and Cell Biology·Myron M Levine, Roy Robins-Browne
Nov 4, 2016·The American Journal of Clinical Nutrition·Pantea NazeriFereidoun Azizi
Feb 8, 2018·Health Policy and Planning·Olivier SterckStefan Thewissen
Sep 24, 2013·Central European Journal of Public Health·S Songül YalçinYasin Erkoç
Oct 1, 2017·Kidney International Supplements·Aminu K BelloAdeera Levin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.